United States · Series D startup
6 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$91Mraised across 6 rounds since 2010, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $6.5M sold, first sale Apr 2014
Reported by sec.govSEC filing: $18M sold, first sale Jul 2012
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale May 2012
Reported by money.msn.comSEC filing: $11M sold, first sale Jun 2011
Reported by fis.dowjones.comSEC filing: $17M sold, first sale Jun 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ARCH Venture Partners
Sofinnova Investments
Novartis Venture Fund
CMEA VenturesGeneChemMissing a round, or an investor who was in one? Tell us.
Sorbent Therapeutics's investors include ARCH Venture Partners, Sofinnova Investments, Novartis Venture Fund, CMEA Ventures and GeneChem.
Sorbent Therapeutics has raised $91M across 6 rounds since 2010.
Sorbent Therapeutics's most recent round was a Series D of $6.5M in May 2014.
Sorbent Therapeutics's largest round on record is $36M (Series B), in Jun 2011.
Sorbent Therapeutics's first round on record, in Sept 2010, was backed by ARCH Venture Partners, Sofinnova Investments and CMEA Ventures and 1 others.
Sorbent Therapeutics's latest named round is a Series D, in May 2014.
Sorbent Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·